Neuro plus s.r.o.
- Address
- Dlouha 521/34, Lazce, 779 00 Olomouc, Czechia
Neuro plus s.r.o. - Migraine and Headache Research Center
Neuro plus s.r.o. is a specialized neurology research center focused on advancing treatment options for patients suffering from debilitating headache disorders. The center demonstrates particular expertise in migraine prevention and the evaluation of novel therapeutic approaches targeting migraine-related conditions.
- Menstrual Migraine preventive treatment research
- CGRP antagonist efficacy and safety evaluation
- Gender-specific migraine therapy development
The research team at Neuro plus s.r.o. is actively involved in clinical trials investigating innovative pharmacological interventions, including atogepant for the prevention of menstrual migraine. Their clinical research portfolio emphasizes both the efficacy and tolerability of emerging therapies, contributing valuable data to improve quality of life for patients experiencing hormonally-triggered migraine episodes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neuro plus s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Atogepant in the Preventive Treatment of Menstrual Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Mar 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atogepant | 1 | Unknown | 2025-03-05 | 2025-03-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.